Crowley Elizabeth's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Jun 18, 2024
- Accession no.
- 0001415889-24-017362
- Filed
- Jun 18, 2024
- Trade date
- Jun 14, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.05M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crowley ElizabethCIK 0001681854 | Officer (SR. VP & CPDO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | Common Stock | MOption exerciseAcquired | +30,000 | $10.38 | +$311,400 | 39,074 | Direct | |
| Jun 14, 2024 | Common Stock | SSaleDisposed | −30,000 | $34.87 | −$1,046,100 | 9,074 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 46,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.